BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hsu CY, Lin YS, Weng WC, Panny L, Chen HL, Tung MC, Ou YC, Lin CC, Yang CH. Phloretin Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Regulating the Inflammatory Response, Oxidative Stress and Apoptosis. Life (Basel) 2021;11:743. [PMID: 34440487 DOI: 10.3390/life11080743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang CH, Ou YC, Lin CC, Lin YS, Tung MC, Yu CC, Lin JT, Wen CY. Phloretin in Benign Prostate Hyperplasia and Prostate Cancer: A Contemporary Systematic Review. Life (Basel) 2022;12:1029. [PMID: 35888117 DOI: 10.3390/life12071029] [Reference Citation Analysis]
2 Raafat M, Kamel AA, Shehata AH, Ahmed AF, Bayoumi AMA, Moussa RA, Abourehab MAS, El-daly M. Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2. Pharmaceuticals 2022;15:130. [DOI: 10.3390/ph15020130] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]